Moderna, Inc. (BMV:MRNA)
669.00
+21.76 (3.36%)
Feb 14, 2025, 8:30 AM CST
Moderna Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
Operating Revenue | 3,109 | 6,671 | 18,435 | 17,675 | 803 | Upgrade
|
Other Revenue | 127 | 177 | 828 | 796 | - | Upgrade
|
Revenue | 3,236 | 6,848 | 19,263 | 18,471 | 803 | Upgrade
|
Revenue Growth (YoY) | -52.75% | -64.45% | 4.29% | 2200.25% | 1238.33% | Upgrade
|
Cost of Revenue | 6,007 | 9,538 | 8,711 | 4,608 | 1,378 | Upgrade
|
Gross Profit | -2,771 | -2,690 | 10,552 | 13,863 | -575 | Upgrade
|
Selling, General & Admin | 1,174 | 1,549 | 1,132 | 567 | 188 | Upgrade
|
Operating Expenses | 1,174 | 1,549 | 1,132 | 567 | 188 | Upgrade
|
Operating Income | -3,945 | -4,239 | 9,420 | 13,296 | -763 | Upgrade
|
Interest Expense | - | -38 | -29 | -17 | -10 | Upgrade
|
Interest & Investment Income | 425 | 421 | 200 | 18 | 25 | Upgrade
|
Other Non Operating Income (Expenses) | -87 | -14 | 4 | -12 | 4 | Upgrade
|
EBT Excluding Unusual Items | -3,607 | -3,870 | 9,595 | 13,285 | -744 | Upgrade
|
Gain (Loss) on Sale of Investments | - | -72 | -20 | - | - | Upgrade
|
Pretax Income | -3,607 | -3,942 | 9,575 | 13,285 | -744 | Upgrade
|
Income Tax Expense | -46 | 772 | 1,213 | 1,083 | 3 | Upgrade
|
Net Income | -3,561 | -4,714 | 8,362 | 12,202 | -747 | Upgrade
|
Net Income to Common | -3,561 | -4,714 | 8,362 | 12,202 | -747 | Upgrade
|
Net Income Growth | - | - | -31.47% | - | - | Upgrade
|
Shares Outstanding (Basic) | 384 | 382 | 394 | 403 | 381 | Upgrade
|
Shares Outstanding (Diluted) | 384 | 382 | 416 | 431 | 381 | Upgrade
|
Shares Change (YoY) | 0.52% | -8.17% | -3.48% | 13.12% | 15.11% | Upgrade
|
EPS (Basic) | -9.27 | -12.34 | 21.22 | 30.28 | -1.96 | Upgrade
|
EPS (Diluted) | -9.28 | -12.34 | 20.12 | 28.29 | -1.96 | Upgrade
|
EPS Growth | - | - | -28.88% | - | - | Upgrade
|
Free Cash Flow | -4,055 | -3,825 | 4,581 | 13,336 | 1,959 | Upgrade
|
Free Cash Flow Per Share | -10.56 | -10.01 | 11.01 | 30.94 | 5.14 | Upgrade
|
Gross Margin | -85.63% | -39.28% | 54.78% | 75.05% | -71.61% | Upgrade
|
Operating Margin | -121.91% | -61.90% | 48.90% | 71.98% | -95.02% | Upgrade
|
Profit Margin | -110.04% | -68.84% | 43.41% | 66.06% | -93.03% | Upgrade
|
Free Cash Flow Margin | -125.31% | -55.86% | 23.78% | 72.20% | 243.96% | Upgrade
|
EBITDA | -3,756 | -3,618 | 9,768 | 13,528 | -732 | Upgrade
|
EBITDA Margin | -116.07% | -52.83% | 50.71% | 73.24% | -91.16% | Upgrade
|
D&A For EBITDA | 189 | 621 | 348 | 232 | 31 | Upgrade
|
EBIT | -3,945 | -4,239 | 9,420 | 13,296 | -763 | Upgrade
|
EBIT Margin | -121.91% | -61.90% | 48.90% | 71.98% | -95.02% | Upgrade
|
Effective Tax Rate | - | - | 12.67% | 8.15% | - | Upgrade
|
Revenue as Reported | 3,236 | 6,848 | 19,263 | 18,471 | 803 | Upgrade
|
Advertising Expenses | - | 204 | 121 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.